TrialGastroenterology2014

CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.

Stacey Shiovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.